Clinical Trials Browser

Circulating Tumor DNA × Clear all

NCT05987241 2026-03-18

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Phase 2/3 Recruiting

Muscle Invasive Bladder Urothelial Carcinoma

NCT07142226 2026-03-18

Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC

Gastrointestinal

Biliary Tract Neoplasms

NCT05429320 2026-02-02

A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual

NCT07125729 2025-08-15

Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients

Phase NA Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06537154 2025-07-30

NEO-BLAST

Phase 2/3 Recruiting

Urinary Bladder Neoplasms

NCT04046575 2025-07-11

Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer

Phase 1 Active not recruiting

Gastrointestinal

Esophageal Neoplasms

NCT04846933 2025-01-16

DECIDER

Phase NA Recruiting

Ovarian Neoplasms

NCT05601505 2024-12-24

CINTS-R

Phase 2 Recruiting

Gastrointestinal

Locally Advanced Rectal Carcinoma

NCT05940311 2024-11-27

VerSiLiB

Melanoma

NCT03973918 2024-10-31

BRAF

Phase 2 Terminated

5 enrolled 15 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

NCT06582108 2024-09-03

ROAR

Not yet recruiting

Vulvar Neoplasms

NCT04920344 2023-11-03

Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy

Phase 2 Unknown

Oropharyngeal Neoplasms

NCT05702619 2023-01-27

HYPROGEN

Hypoxia, Prostatic Neoplasms

NCT05635630 2022-12-02

Predictive Value of ctDNA for NED Status in mCRC and Its Utility in Guiding Therapeutic Intervention

Phase NA Unknown

Gastrointestinal

Colorectal Neoplasms

NCT05158621 2022-10-18

A Screening Study Targeting Tumor-specific Antigens

Gastrointestinal

Colorectal Neoplasms

NCT04555369 2021-07-19

The Value of ctDNA on Chemotherapy Efficacy for mCRC

Phase NA Unknown

Circulating Tumor DNA

NCT03115138 2020-07-15

Bi-GLAM

Phase NA Terminated

Glioblastoma, Genetic Diseases, Inborn

NCT03957564 2020-01-22

Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer

Phase 2 Unknown

Gastrointestinal

Neoplastic Cells, Circulating, Stomach Neoplasms